Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007

Pediatrics

Volumn 127, Issue 3, 2011, Pages 411-418

  Kronman, Matthew P ^a,b   Hersh, Adam L ^c   Feng, Rui ^b   Huang, Yuan Shung ^a   Lee, Grace E ^a   Shah, Samir S ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibiotic use; Epidemiology; Physician practice patterns; Pneumococcal conjugate vaccine; Pneumonia

Indexed keywords

CEPHALOSPORIN; MACROLIDE; PENICILLIN G;

ADULT; AGE; ALGORITHM; AMBULATORY CARE; ARTICLE; BLOOD CELL COUNT; CHILD; COMMUNITY ACQUIRED PNEUMONIA; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPECTRUM; X RAY FILM;

ADOLESCENT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INFANT; MALE; OFFICE VISITS; OUTPATIENTS; PNEUMONIA; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 79952219921     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-2008     Document Type: Article

References (30)

1. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86(5):408-416 (Pubitemid 351694322)
2. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49(RR-9):1-35
3. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007;369(9568):1179-1186 (Pubitemid 46527876)
4. Peck AJ, Holman RC, Curns AT, et al. Lower respiratory tract infections among american Indian and Alaska Native children and the general population of U.S. children. Pediatr Infect Dis J. 2005;24(4):342-351 (Pubitemid 40525343)
5. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302(7):758-766
6. Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006;118(3):865-873 (Pubitemid 46090026)
7. Nelson JC, Jackson M, Yu O, et al. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine. 2008;26(38):4947-4954
8. Kyaw MH, Lynfield R, Schaffner W, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;354(14):1455-1463
9. Cardoso MR, Nascimento-Carvalho CM, Ferrero F, et al. Penicillin-resistant pneumococcus and risk of treatment failure in pneumonia. Arch Dis Child. 2008;93(3):221-225 (Pubitemid 352025494)
10. Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003;37(2):230-237 (Pubitemid 36930354)
11. Furuno JP, Metlay JP, Harnett JP, et al. Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections. Pharmacoepidemiol Drug Saf. 2006;15(1):1-9 (Pubitemid 43174180)
12. Stille CJ, Andrade SE, Huang SS, et al. Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States. Pediatrics. 2004;114(5):1206-1211 (Pubitemid 41647678)
13. Perez-Trallero E, Marimon JM, Iglesias L, Larruskain J. Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates. Emerg Infect Dis. 2003;9(9):1159-1162 (Pubitemid 37071561)
14. Daneman N, McGeer A, Green K, Low DE. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis. 2006;43(4):432-438 (Pubitemid 44157150)
15. Centers for Disease Control and Prevention: About the ambulatory health care surveys [article online], updated July 15, 2009. Available at: www.cdc.gov/nchs/ahcd/about- ahcd.htm. Accessed Jan 22, 2010
16. Shah SS, Wood SM, Luan X, Ratner AJ. Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Pediatr Infect Dis J. 2010;29(3):199-204
17. Centers for Disease Control and Prevention: Ambulatory health care data: NAMCS and NHAMCS survey data files [article online]. Available at: www.cdc.gov/nchs/ahcd/ ahcd-questionnaires.htm. Accessed Jan 22, 2010
18. Whittle J, Fine MJ, Joyce DZ, et al. Community-acquired pneumonia: can it be defined with claims data? Am J Med Qual. 1997;12(4):187-193 (Pubitemid 127447173)
19. Feudtner C, Christakis DA, Connell FA. Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980-1997. Pediatrics. 2000;106(1 pt 2):205-209
20. Lee GE, Lorch SA, Sheffler-Collins S, Kronman MP, Shah SS. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics. 2010;126(2):204-213
21. Page EB. Ordered hypotheses for multiple treatments: a significance test for linear ranks. J Am Stat Assoc. 1963;58(301):216-230
22. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002;21(9):810-815
23. Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, Daley J. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis. 2006;42(8):1093-1101
24. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113(4):701-707 (Pubitemid 38437371)
25. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology. 2004;9(1):109-114 (Pubitemid 38647779)
26. Gavranich JB, Chang AB. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev 2005(3):CD004875
27. Coco AS, Horst MA, Gambler AS. Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998-2004. BMC Pediatr. 2009;9:41
28. Linder JA, Bates DW, Lee GM, Finkelstein JA. Antibiotic treatment of children with sore throat. JAMA. 2005;294(18):2315-2322 (Pubitemid 41607407)
29. Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children. Lancet. 1998;351(9100):404-408
30. Alario AJ, McCarthy PL, Markowitz R, Kornguth P, Rosenfield N, Leventhal JM. Usefulness of chest radiographs in children with acute lower respiratory tract disease. J Pediatr. 1987;111(2):187-193 (Pubitemid 17127130)